Skip to main content
main-content

01.03.2016 | Original Article | Ausgabe 2/2016

Comparative Clinical Pathology 2/2016

A comparative study on antihypertensive and antioxidant properties of phenolic extracts from fruit and leaf of some guava (Psidium guajava L.) varieties

Zeitschrift:
Comparative Clinical Pathology > Ausgabe 2/2016
Autoren:
Adedayo O. Ademiluyi, Ganiyu Oboh, Opeyemi B. Ogunsuyi, Funmilayo M. Oloruntoba

Abstract

Investigation of antihypertensive and antioxidant properties of fruit and leaf extracts from four varieties (giant white, small white, stripped and pink) of guava (Psidium guajava L.) in vitro was the focus of this study. Consequently, methanol/1 M HCl (20:1 v/v) extraction of fruit and leaf of the guava varieties were carried out. Thereafter, the extracts were assayed for their angiotensin I converting enzyme (ACE) inhibitory effect, total phenol and flavonoid contents, reducing property, radicals (DPPH, ABTS•+, hydroxyl and nitric oxide) scavenging ability, Fe2+ chelating ability, and inhibition of Fe2+ and Sodium nitroprusside (SNP) induced lipid peroxidation reactions (in vitro). Furthermore, the phenolic constituents of the extracts were characterised with gas chromatography (GC). The results showed that all the extracts significantly (P < 0.05) inhibited ACE activity, scavenged (DPPH, ABTS•+, nitric oxide and hydroxyl) radicals, chelated Fe2+ and also inhibited Fe2+ and SNP induced lipid peroxidation in rat heart (in vitro). Nevertheless, the pink guava variety had the highest ACE inhibitory and antioxidant properties. In addition, Rosmarinic acid, eugenol, carvacrol, catechin and caffeic acid were the dominant phenolics found in the extracts. The ACE inhibitory effects and antioxidant properties of the guava extracts, which correlates significantly with their phenolic constituents, could largely contribute to their antihypertensive properties as obtained in traditional medicine.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag als Mediziner

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 2/2016

Comparative Clinical Pathology 2/2016 Zur Ausgabe

Neu im Fachgebiet Pathologie

26.01.2021 | Pneumonie | Schwerpunkt: Nicht-neoplastischen Lungenerkrankungen | Ausgabe 1/2021

Radiologische Besonderheiten interstitieller Lungenerkrankungen

21.01.2021 | Sarkoidose | Schwerpunkt: Nicht-neoplastischen Lungenerkrankungen | Ausgabe 1/2021

Übersicht: Granulomatöse Erkrankungen der Lunge

21.01.2021 | Tuberkulose | Schwerpunkt: Nicht-neoplastische Lungenerkrankungen | Ausgabe 1/2021

Molekularpathologie der Tuberkulose

Stellenwert, Methodik und Grenzen